AstraZeneca faces potential fines in China
Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...
The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback